Loading stock data…
FONAR Corporation (FONR)
$19.09
Market Closed
FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Fonar Corp in the Healthcare sector is trading at $19.09 with a market capitalization of $120M. The stock is currently near its 52-week high of $19.16, remaining 12.2% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $26.47M↑ | $25.55M↓ | $26.04M↓ | $27.28M↑ | $27.16M |
| Gross Profit | $11.24M↑ | $9.69M↓ | $10.45M↓ | $11.03M↓ | $12.09M |
| Operating Income | $2.44M↓ | $3.00M↓ | $3.19M↑ | $894,757↓ | $3.66M |
| Net Income | $1.64M↓ | $2.06M↓ | $2.26M↑ | $729,261↓ | $2.51M |
Peer Comparison
JNJUNHPFE
Fundamentals
FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$120.20M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
3.75%
Volume
Today's trading volume
935,991
Recent News
Fonar: Fiscal Q2 Earnings Snapshot
MELVILLE, N.Y. (AP) — Fonar Corp. FONR) on Friday reported earnings of $2.1 million in its fiscal second quarter. On a per-share basis, the Melville, New York-based company said it had net income of 31 cents.
Sector Update: Health Care Stocks Edge Higher Premarket Tuesday
Health care stocks were edging higher premarket Tuesday, with the State Street Health Care Select Se
Fonar to Be Taken Private by CEO Timothy Damadian-led Investors in All-Cash Deal
Fonar (FONR) said Tuesday it has entered into a definitive agreement on Dec. 23 to be fully acquired
FONAR Stock Gains Post Y/Y Decline in Q1 Earnings and Profit
FONR reports top-line growth for first-quarter fiscal 2026 amid earnings decline and increased SG&A and operating expenses.
Fonar: Fiscal Q1 Earnings Snapshot
MELVILLE, N.Y. (AP) — Fonar Corp. FONR) on Monday reported earnings of $2.3 million in its fiscal first quarter. The Melville, New York-based company said it had net income of 34 cents per share.